Literature DB >> 32472531

Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis.

Padmini Iriventi1, N Vishal Gupta2, Riyaz Ali M Osmani3, V Balamuralidhara2.   

Abstract

BACKGROUND: Combination of curcumin with anti-inflammatory drug like caffeine shows augmented antipsoriatic action compared to curcumin alone and reduce the time taken for treatment of Psoriasis.
OBJECTIVE: The objective of the present study was to develop nanosponge (NS) based topical gel of curcumin (CUR) and caffeine (CFN) combination that acts as a potential system for the treatment of psoriasis.
METHODS: NS composed of dimethyl carbonate (DMC) as crosslinker and beta-cyclodextrin (β-CD) as polymer were prepared by hot melt method and incorporated in topical gels. Factorial design (32) was constructed in a fully randomized manner to study all nine possible experimental runs. The gels were prepared by varying the content of carbopol-934 (gelling agent) (X1) and guar gum (polymer) (X2). The effect of these two independent variables on viscosity (Y1) and in vitro percent drug release (Y2) of prepared gels was evaluated. Other evaluation studies for NS and nanogels were conducted. In vivo animal studies were carried out for optimized formulation using mouse model of imiquimod-induced psoriasis.
RESULTS: The physical and chemical characteristics exhibited by the prepared NS and gels (F1-F9) were found to be optimal. The optimization resulted in achieving formulation N10 with 69.72% in vitro drug release and 12,329.78cp viscosity. Histopathology studies revealed that prepared nanogel has promising anti-psoriatic activity. The results concluded that CUR and CFN combination has reduced the time required for showing anti-psoriatic activity to 10 days when compared to CUR alone that took around 20 days. Moreover, the nanogel has depicted sustained drug release till 12 h.
CONCLUSIONS: From the experimental findings it has been concluded that CUR and CFN combination significantly augmented the anti-psoriatic efficacy with respect to individual components and also reduced the time required for onset of effect. Thus, the proposed nanogel would be an imperative drug delivery system for more effective anti-psoriatic therapy. Graphical abstract.

Entities:  

Keywords:  Caffeine; Curcumin; Imiquimod; Nanosponges; Psoriasis; Topical drug delivery; Topical gel

Year:  2020        PMID: 32472531      PMCID: PMC7704870          DOI: 10.1007/s40199-020-00352-x

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  20 in total

Review 1.  Chemopreventive and therapeutic effects of curcumin.

Authors:  Annelyse Duvoix; Romain Blasius; Sylvie Delhalle; Michaël Schnekenburger; Franck Morceau; Estelle Henry; Mario Dicato; Marc Diederich
Journal:  Cancer Lett       Date:  2004-11-11       Impact factor: 8.679

Review 2.  Pathogenesis and therapy of psoriasis.

Authors:  Michelle A Lowes; Anne M Bowcock; James G Krueger
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

Review 3.  Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.

Authors:  Sai V Chilajwar; Priti P Pednekar; Kisan R Jadhav; Gajendra J C Gupta; Vilasrao J Kadam
Journal:  Expert Opin Drug Deliv       Date:  2013-12-04       Impact factor: 6.648

4.  Mouse model of imiquimod-induced psoriatic itch.

Authors:  Kent Sakai; Kristen M Sanders; Marina R Youssef; Kevin M Yanushefski; Liselotte Jensen; Gil Yosipovitch; Tasuku Akiyama
Journal:  Pain       Date:  2016-11       Impact factor: 7.926

Review 5.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Authors:  Reason Wilken; Mysore S Veena; Marilene B Wang; Eri S Srivatsan
Journal:  Mol Cancer       Date:  2011-02-07       Impact factor: 27.401

6.  Differential expression and regulation of prohibitin during curcumin-induced apoptosis of immortalized human epidermal HaCaT cells.

Authors:  Hai-Bo Yang; Wei Song; Lan-Ying Chen; Qi-Fu Li; Song-Lin Shi; Hai-Yan Kong; Pu Chen
Journal:  Int J Mol Med       Date:  2014-01-09       Impact factor: 4.101

Review 7.  Psoriasis Pathogenesis and Treatment.

Authors:  Adriana Rendon; Knut Schäkel
Journal:  Int J Mol Sci       Date:  2019-03-23       Impact factor: 5.923

8.  Microsponges based novel drug delivery system for augmented arthritis therapy.

Authors:  Riyaz Ali M Osmani; Nagesh H Aloorkar; Dipti J Ingale; Parthasarathi K Kulkarni; Umme Hani; Rohit R Bhosale; Dandasi Jayachandra Dev
Journal:  Saudi Pharm J       Date:  2015-03-07       Impact factor: 4.330

Review 9.  Use of Curcumin in Psoriasis.

Authors:  Veronica Di Nardo; Serena Gianfaldoni; Georgi Tchernev; Uwe Wollina; Victoria Barygina; Jacopo Lotti; Farah Daaboul; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21

Review 10.  Potential of Curcumin in Skin Disorders.

Authors:  Laura Vollono; Mattia Falconi; Roberta Gaziano; Federico Iacovelli; Emi Dika; Chiara Terracciano; Luca Bianchi; Elena Campione
Journal:  Nutrients       Date:  2019-09-10       Impact factor: 5.717

View more
  6 in total

Review 1.  Novel Gels: An Emerging Approach for Delivering of Therapeutic Molecules and Recent Trends.

Authors:  Trideva K Sastri; Vishal N Gupta; Souvik Chakraborty; Sharadha Madhusudhan; Hitesh Kumar; Pallavi Chand; Vikas Jain; Balamuralidhara Veeranna; Devegowda V Gowda
Journal:  Gels       Date:  2022-05-19

2.  Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.

Authors:  Hadeia Mashaqbeh; Rana Obaidat; Nizar Al-Shar'i
Journal:  Polymers (Basel)       Date:  2021-11-24       Impact factor: 4.329

Review 3.  Cyclodextrin-Based Nanosponges: Overview and Opportunities.

Authors:  Gianluca Utzeri; Pedro M C Matias; Dina Murtinho; Artur J M Valente
Journal:  Front Chem       Date:  2022-03-24       Impact factor: 5.221

4.  How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions.

Authors:  Yaseen Hussain; Haroon Khan; Ghallab Alotaibi; Fazlullah Khan; Waqas Alam; Michael Aschner; Philippe Jeandet; Luciano Saso
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

5.  Preparation, Characterization and Evaluation of the Anti-Inflammatory Activity of Epichlorohydrin-β-Cyclodextrin/Curcumin Binary Systems Embedded in a Pluronic®/Hyaluronate Hydrogel.

Authors:  Ana-María Fernández-Romero; Francesca Maestrelli; Sara García-Gil; Elena Talero; Paola Mura; Antonio M Rabasco; María Luisa González-Rodríguez
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

6.  Poly ε-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model.

Authors:  Ekta Singh; Riyaz Ali M Osmani; Rinti Banerjee; Amr Selim Abu Lila; Afrasim Moin; Khaled Almansour; Hany H Arab; Hadil Faris Alotaibi; El-Sayed Khafagy
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.